Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

CERETEC

TECHNETIUM TC-99M EXAMETAZIME KIT

Standard Dose
N/A
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview CERETEC is listed in Drugs@FDA under application 019829 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TECHNETIUM TC-99M EXAMETAZIME KIT Form and strength INJECTABLE;INJECTION - N/A Sponsor GE HEALTHCARE Submission history Latest submission status date: 2018-09-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview CERETEC is listed in Drugs@FDA under application 019829 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TECHNETIUM TC-99M EXAMETAZIME KIT Form and strength INJECTABLE;INJECTION - N/A Sponsor GE HEALTHCARE Submission history Latest submission status date: 2018-09-19 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.